DocMorris AG (DOCM.SW)
- Previous Close
22.00 - Open
20.90 - Bid 20.40 x --
- Ask 20.44 x --
- Day's Range
19.74 - 21.80 - 52 Week Range
14.90 - 76.85 - Volume
255,636 - Avg. Volume
136,633 - Market Cap (intraday)
241.057M - Beta (5Y Monthly) 1.87
- PE Ratio (TTM)
-- - EPS (TTM)
-8.25 - Earnings Date Mar 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
30.60
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products. It also provides professional health care services. The company sells its products to online mail-order pharmacies, and private individuals under the PromoFarma by DocMorris, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
corporate.docmorris.com/en1,454
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DOCM.SW
View MorePerformance Overview: DOCM.SW
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DOCM.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DOCM.SW
View MoreValuation Measures
Market Cap
259.96M
Enterprise Value
476.80M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.26
Price/Book (mrq)
0.76
Enterprise Value/Revenue
0.47
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-9.56%
Return on Assets (ttm)
-7.84%
Return on Equity (ttm)
-25.24%
Revenue (ttm)
1.02B
Net Income Avi to Common (ttm)
-97.25M
Diluted EPS (ttm)
-8.25
Balance Sheet and Cash Flow
Total Cash (mrq)
95.37M
Total Debt/Equity (mrq)
91.79%
Levered Free Cash Flow (ttm)
41.4M